Page 103 - AN-4-2
P. 103

Advanced Neurology                                                   PVT in Indonesian neurological patients



               American Academy of Clinical Neuropsychology consensus   13.  Lippa SM. Performance validity testing in neuropsychology:
               conference statement on the neuropsychological assessment   A  clinical guide, critical review, and update on a rapidly
               of effort, response bias, and malingering. Clin Neuropsychol.   evolving literature. Clin Neuropsychol. 2018;32(3):391-421.
               2009;23(7):1093-1129.                              doi: 10.1080/13854046.2017.1406146
               doi: 10.1080/13854040903155063                  14.  Roor JJ, Peters MJV, Dandachi-FitzGerald B, Ponds RWH.
            4.   Larrabee GJ. Performance validity and symptom validity   Performance validity test failure in the clinical population :
               in neuropsychological assessment.  J  Int Neuropsychol Soc.   A systematic review and meta-nalysis of prevalence rates.
               2012;18(4):625-631.                                Neuropsychol Rev. 2023;34:299-319.
               doi: 10.1017/S1355617712000240                     doi: 10.1007/s11065-023-09582-7
            5.   Schroeder RW, Martin PK. Validity assessment in clinical   15.  Larrabee GJ. Aggregation across multiple indicators
               settings: How it differs from forensic settings and why   improves the detection of malingering: Relationship to
               it is important. In: Schroeder RW, Martin PK, editors.   likelihood ratios. Clin Neuropsychol. 2008;22(4):666-679.
               Validity Assessment in Clinical Neuropsychological Practice:      doi: 10.1080/13854040701494987
               Evaluating  and  Managing  Noncredible  Performance.
               New York, USA: The Guilford Press; 2022. p. 3-10.  16.  McWhirter L, Ritchie CW, Stone J, Carson A. Performance
                                                                  validity test failure in clinical populations-a systematic
            6.   Suchy Y. Introduction to special issue: Current trends in   review. J Neurol Neurosurg Psychiatry. 2020;91:945-952.
               empirical examinations of performance and symptom
               validity. Clin Neuropsychol. 2019;33(8):1349-1353.     doi: 10.1136/jnnp-2020-323776
                                                               17.  Greher MR, Wodushek TR. Performance validity testing in
               doi: 10.1080/13854046.2019.1672334
                                                                  neuropsychology: Scientific basis and clinical application-A
            7.   Schroeder RW, Martin PK. Validity assessment within the   brief review. J Psychiatr Pract. 2017;23(2):134-140.
               memory disorders/dementia clinic. In: Schroeder  RW,
               Martin PK, editors.  Validity Assessment in Clinical      doi: 10.1097/PRA.0000000000000218
               Neuropsychological  Practice:  Evaluating  and  Managing   18.  Wodushek TR, Domen CH. Comparing two models of
               Noncredible Performance. New  York: The Guilford Press;   performance validity assessment in patients with Parkinson’s
               2022. p. 254-279.                                  disease who are candidates for deep brain stimulation
                                                                  surgery. Appl Neuropsychol Adult. 2020;27(1):9-21.
            8.   Martin PK, Schroeder RW. Base rates of invalid test
               performance across clinical non-forensic contexts and      doi: 10.1080/23279095.2018.1473251
               settings. Arch Clin Neuropsychol. 2020;35(6):717-725.  19.  Singhal A, Green P, Ashaye K, Shankar K, Gill D. High
               doi: 10.1093/arclin/acaa017                        specificity of the medical symptom validity test in
                                                                  patients with very severe memory impairment.  Arch Clin
            9.   Martin PK, Schroeder RW, Olsen DH. Performance validity   Neuropsychol. 2009;24(8):721-728.
               in the dementia clinic: Specificity of validity tests when
               used individually and in aggregate across levels of cognitive      doi: 10.1093/arclin/acp074
               impairment severity. Clin Neuropsychol. 2022;36(1):165-188.  20.  American Psychiatric Association. Diagnostic and Statistical
                                                                                           th
               doi: 10.1080/13854046.2020.1778790                 Manual of Mental Disorders. 4   ed. Washington, DC:
                                                                  American Psychiatric Association; 1994.
            10.  Ownsworth T, Fleming JM, Hardwick S. Symptom reporting
               and associations with compensation status, self-awareness,   21.  Dean AC, Victor TL, Boone KB, Philpott LM, Hess RA.
               causal  attributions,  and  emotional  wellbeing  following   Dementia and effort test performance.  Clin Neuropsychol.
               traumatic brain injury. Brain Impair. 2006;7(2):95-106.  2009;23(1):133-152.
               doi: 10.1375/brim.7.2.95                           doi: 10.1080/13854040701819050
            11.  Nauta IM, Bertens D, van Dam M,  et  al. Performance   22.  Adhiatma W, Hendriks MPH, Halim MS, Kessels RPC. The
               validity in outpatients with multiple sclerosis and cognitive   validation of multiple performance validity tests (PVTs) for
               complaints. Mult Scler J. 2022;28(4):642-653.      Indonesia. Psychol Neurosci. 2025.
               doi: 10.1177/13524585211025780                     doi: 10.1037/pne0000340
            12.  Loring DW, Goldstein FC, Chen C, et al. False-positive error   23.  Dandachi-Fitzgerald B, Ponds RWH, Peters MJV,
               rates for reliable digit span and auditory verbal learning test   Merckelbach H. Cognitive underperformance and
               performance validity measures in amnestic mild cognitive   symptom over-reporting in a mixed psychiatric sample. Clin
               impairment and early Alzheimer disease.  Arch Clin   Neuropsychol. 2011;25(5):812-828.
               Neuropsychol. 2016;31(4):313-331.                  doi: 10.1080/13854046.2011.583280
               doi: 10.1093/arclin/acw014                      24.  Boone KB, Victor TL, Wen J, Razani J, Pontón M. The


            Volume 4 Issue 2 (2025)                         97                               doi: 10.36922/an.5661
   98   99   100   101   102   103   104   105   106   107   108